Gilead Sciences (GILD) Fails to deliver data

Key failure to deliver metrics for Gilead Sciences:

• Last SEC data release: 2025-01-14
• Last 15 days FTD volume: €0.73 M
• Last 3 months FTD volume: €31.81 M
• Last year FTD volume: €31.81 M

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Gilead Sciences (GILD) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Gilead Sciences (GILD) - since 2013

Gilead Sciences (GILD) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Amgen AMGN	€36.48 M	€0.25 B	🇺🇸 USA
Vertex Pharmaceuticals VRTX	€21.31 M	€44.63 M	🇺🇸 USA
AbbVie ABBV	€51.14 M	€0.19 B	🇺🇸 USA
Illumina ILMN	€20.26 M	€65.96 M	🇺🇸 USA
Biogen BIIB	€24.82 M	€71.78 M	🇺🇸 USA
Pfizer PFE	€28.68 M	€0.33 B	🇺🇸 USA
Johnson & Johnson JNJ	€21.76 M	€0.31 B	🇺🇸 USA
Eli Lilly LLY	€76.39 M	€0.20 B	🇺🇸 USA
Merck MRK	€76.76 M	€0.12 B	🇺🇸 USA